Keta Medical Center

Dr. Cheryl Malina, a board-certified Emergency Medicine physician, is the co-founder of Keta Medical Center. With over 15 years of experience, Dr. Malina has practiced extensively in hospitals across the Bronx and Westchester. She graduated Phi Beta Kappa from Barnard College at Columbia University and earned her medical degree from Albert Einstein College of Medicine, completing her residency at the Jacobi/Montefiore EM Program. Dr. Malina later moved to attending physician roles at several hospitals, most recently as an attending physician at the Good Samaritan Hospital in Suffern, New York. Dr. Malinas interest in ketamine therapy was sparked during the COVID-19 pandemic, as she observed a surge in acute psychiatric cases. Impressed by the rapid, positive changes ketamine brought in patients she became a strong advocate for its use in treating conditions like depression, anxiety, and PTSD.

Dr. Haviva Malina, a licensed Emergency Medicine physician with over 15 years of ER experience, became a proponent of ketamine therapy after witnessing its transformative effects on patients with treatment resistant depression, anxiety, PTSD and other mood disorders. She graduated Phi Beta Kappa from Barnard College of Columbia University and earned her medical degree from Albert Einstein College of Medicine, completing her residency training at the combined Jacobi/ Montefiore EM Program. Dr. Malina later worked as an attending physician at Hoboken University Medical Center, New Jersey. Dr. Malinas interest in ketamine therapy was spurred by her experiences during the COVID-19 pandemic, where she observed an increase in acute psychiatric cases and recognized the urgent need for more effective treatments. Motivated by the need for effective mood disorder treatments, she founded Keta Medical Center. Dr. Malina champions the benefits of ketamine and its ability to provide substantial improvements in patients functionality and well-being. At her clinic, she ensures a supportive environment, collaborates on comprehensive treatment plans, and advocates for better access to therapies like Spravato.